Report cover image

Anti Infective Drugs Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 198 Pages
SKU # FAVR20573045

Description

Anti-Infective Drugs Market Size And Forecast

According to Factview Research, Global Anti-Infective Drugs Market was valued at USD 89.7 Billion in 2024 and is projected to reach USD 165.92 Billion by 2034, growing at a CAGR of 7.0% from 2025 to 2034.

Global Anti-Infective Drugs Market Outlook

The growing burden of several infectious diseases across the developed and emerging markets such as different types of influenza, diarrhea, hepatitis, and urinary tract infections, that requires the more attention from pharmaceutical and biotechnological companies. This, in turn, the primary factor for the growth of the Global anti-infective drug market. The development of new multi-drug resistance against micro-organisms is another factor further expected to fuel the growth of the market. However, high investment costs in research and development and shortage of resources in healthcare facilities are the factors that might restrict the market growth.

Global Anti-Infective Drugs Market Competitive Landscape

The Global Anti-Infective Drugs Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Novartis, Merck & Co., Johnson & Johnson, GlaxoSmithKline plc, Gilead Sciences, Boehringer Ingelheim GmbH, Pfizer, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd.

Table of Contents

198 Pages
1 Introduction Of Global Anti-infective Drugs Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Anti-infective Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Anti-infective Drugs Market, By Product Type
5.1 Overview
5.2 Antibiotics
5.3 Antivirals
5.4 Antifungals
5.5 Others
6 Global Anti-infective Drugs Market, By Indication
6.1 Overview
6.2 Hiv Infection
6.3 Pneumonia
6.4 Respiratory Virus Infection
6.5 Sepsis
6.6 Tuberculosis
6.7 Others
7 Global Anti-infective Drugs Market, By Distribution Channel
7.1 Overview
7.2 Hospital Pharmacy
7.3 Retail Pharmacy
7.4 Others
8 Global Anti-infective Drugs Market, By Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest Of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest Of Asia Pacific
8.5 Rest Of The World
8.5.1 Latin America
8.5.2 Middle East
9 Global Anti-infective Drugs Market Competitive Landscape
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 Company Profiles
10.1 Novartis
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Merck &Amp; Co.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Johnson &Amp; Johnson
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Glaxosmithkline Plc
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Gilead Sciences
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Boehringer Ingelheim Gmbh
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Pfizer
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Teva Pharmaceutical Industries Ltd.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Bristol-myers Squibb
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 F. Hoffmann-la Roche Ltd.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Research

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us